Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis

Infection and Immunity

Volumn 72, Issue 6, 2004, Pages 3294-3298

  Angstwurm, Klemens ^a   Hanisch, Uwe Karsten ^b   Gassemi, Tarraneh ^a   Bille, Margrethe Bastholm ^a   Prinz, Marco ^b,c   Dirnagl, Ulrich ^a   Kettenmann, Helmut ^b   Weber, Joerg R ^a,d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROTEIN TYROSINE KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; TYRPHOSTIN; TYRPHOSTIN AG 126; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL MENINGITIS; BRAIN BLOOD FLOW; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; DRUG EFFECT; ENZYME INHIBITION; INFLAMMATION; INTRACRANIAL HYPERTENSION; LEUKOCYTE MIGRATION; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PNEUMONIAE;

ACUTE DISEASE; ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; ENZYME INHIBITORS; INFLAMMATION; INTRACRANIAL PRESSURE; MALE; MENINGITIS, PNEUMOCOCCAL; PROTEIN-TYROSINE KINASES; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; TUMOR NECROSIS FACTOR-ALPHA; TYRPHOSTINS;

EID: 2542532366     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.6.3294-3298.2004     Document Type: Article

References (35)

1. Angstwurm, K., D. Freyer, U. Dirnagl, U. K. Hanisch, R. R. Schumann, K. M. Einhaupl, and J. R. Weber. 1998. Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, but augments experimental meningitis. Neuroscience 86:627-634.
2. Angstwurm, K., S. Reuss, D. Freyer, G. Arnold, U. Dirnagl, R. R. Schumann, and J. R. Weber. 2000. Induced hypothermia in experimental pneumococcal meningitis. J. Cereb. Blood Flow Metab. 20:834-838.
3. Bohr, V., N. Rasmussen, B. Hansen, H. Kjersem, O. Jessen, N. Johnsen, and H. S. Kristensen. 1983. 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series. J. Infect. 7:193-202.
4. Braun, J. S., R. Novak, K. H. Herzog, S. M. Bodner, J. L. Cleveland, and E. I. Tuomanen. 1999. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat. Med. 5:298-302.
5. 2 mediate brain cell apoptosis during meningitis. J. Clin. Investig. 109:19-27.
6. Brenner, T., E. Poradosu, D. Soffer, C. Sicsic, A. Gazit, and A. Levitzki. 1998. Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556. Exp. Neurol. 154:489-498.
7. Constantin, G., S. Brocke, A. Izikson, C. Laudanna, and E. C. Butcher. 1998. Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:3523-3529.
8. Constantin, G., C. Laudanna, S. Brocke, and E. C. Butcher. 1999. Inhibition of experimental autoimmune encephalomyelitis by a tyrosine kinase inhibitor. J. Immunol. 162:1144-1149.
9. de Gans, J., and D. van de Beek. 2002. Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 347:1549-1556.
10. Dugo, L., P. K. Chatterjee, E. Mazzon, M. C. McDonald, R. D. Paola, F. Fulia, A. P. Caputi, C. Thiemermann, and S. Cuzzocrea. 2002. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat. Intensive Care Med. 28:775-788.
11. Fischer, H., and A. Tomasz. 1984. Production and release of peptidoglycan and wall teichoic acid polymers in pneumococci treated with beta-lactam antibiotics. J. Bacteriol. 157:507-513.
12. Freyer, D., R. Manz, A. Ziegenhorn, M. Weih, K. Angstwurm, W. D. Docke, A. Meisel, R. R. Schumann, G. Schonfelder, U. Dirnagl, and J. R. Weber. 1999. Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J. Immunol. 163:4308-4314.
13. Freyer, D., M. Weih, J. R. Weber, W. Bürger, P. Scholz, R. Manz, A. Ziegenhorn, K. Angstwurm, and U. Dirnagl. 1996. Pneumococcal cell wall components induce nitric oxide synthase and TNF-alpha in astroglial-enriched cultures. Glia 16:1-6.
14. Hanisch, U. K., M. Prinz, K. Angstwurm, K. G. Hausler, O. Kann, H. Kettenmann, and J. R. Weber. 2001. The protein tyrosine kinase inhibitor AG 126 prevents the massive microglial cytokine induction by pneumococcal cell walls. Eur. J. Immunol. 31:2104-2115.
15. Holtje, J. V., and A. Tomasz. 1975. Specific recognition of choline residues in the cell wall teichoic acid by the N-acetylmuramyl-L-alanine amidase of pneumococcus. J. Biol. Chem. 250:6072-6076.
16. Kelly, S. A., C. P. Goldschmidt, E. E. Milliken, T. Arai, E. H. Smith, and G. B. Bulkley. 1998. Protein tyrosine phosphorylation mediates TNF-induced endothelial-neutrophil adhesion in vitro. Am. J. Physiol. 274:H513-H519.
17. Leist, T. P., K. Frei, S. Kam-Hansen, R. M. Zinkernagl, and A. Fontana. 1988. Tumor necrosis factor alpha (TNF alpha) in CSF during bacterial, but not viral meningitis: evaluation in murine model infections and in patients. J. Exp. Med. 167:1743-1748.
18. Novogrodsky, A., A. Vanichkin, M. Patya, A. Gazit, N. Osherov, and A. Levitzki. 1994. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-1322.
19. Pfister, H. W., U. Koedel, S. Lorenzl, and A. Tomasz. 1992. Antioxidants attenuate microvascular changes in the early phase of experimental pneumoccocal meningitis in rats. Stroke 23:1798-1804.
20. Prinz, M., O. Kann, H. J. Draheim, R. R. Schumann, H. Kettenmann, J. R. Weber, and U. K. Hanisch. 1999. Microglial activation by components of gram-positive and -negative bacteria: distinct and common routes to the induction of ion channels and cytokines. J. Neuropathol. Exp. Neurol. 58:1078-1089.
21. Quagliarello, V., and M. Scheld. 1992. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 327:864-872.
22. Scheld, W. M., R. G. Dacey, H. R. Winn, J. E. Welsh, J. A. Jane, and M. A. Sande. 1980. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J. Clin. Investig. 66:243-253.
23. Schneider, O., U. Michel, G. Zysk, O. Dubuis, and R. Nau. 1999. Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations. Neurology 53:1584-1587.
24. Schuchat, A., K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, and B. A. Perkins. 1997. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 337:970-976.
25. Schumann, R. R., D. Pfeil, D. Freyer, W. Buerger, N. Lamping, C. J. Kirschning, U. B. Goebel, and J. R. Weber. 1998. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes. Glia 22:295-305.
26. Sevransky, J. E., G. Shaked, A. Novogrodsky, A. Levitzki, A. Gazit, A. Hoffman, R. J. Elin, Z. M. Quezado, B. D. Freeman, P. Q. Eichacker, R. L. Danner, S. M. Banks, J. Bacher, M. L. Thomas, and C. Natanson. 1997. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis. J. Clin. Investig. 99:1966-1973.
27. Tomasz, A. 1981. Surface components of Streptococcus pneumoniae. Rev. Infect. Dis. 3:190-211.
28. Tuomanen, E., H. Liu, B. Hengstler, O. Zak, and A. Tomasz. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151:859-868.
29. Tuomanen, E. I., K. Saukkonen, S. Sande, C. Cioffe, and S. D. Wright. 1989. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med. 170:959-968.
30. Waage, A., A. Halstensen, R. Shalaby, P. Brandtzaeg, P. Kierulf, and T. Espevik. 1988. Local production of tumor necrosis factor alpha, interleukin 1 (IL1), and interleukin 6 (IL6) in meningococcal meningitis. Relation to the inflammatory response. Biochem. J. 255:223-228.
31. Weber, J. R., K. Angstwurm, W. Burger, K. M. Einhaupl, and U. Dirnagl. 1995. Anti ICAM-1 (CD 54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis. J. Neuroimmunol. 63:63-68.
32. Weber, J. R., K. Angstwurm, T. Rosenkranz, U. Lindauer, D. Freyer, W. Burger, C. Busch, K. M. Einhaupl, and U. Dirnagl. 1997. Heparin inhibits leukocyte rolling in pial vessels and attenuates inflammatory changes in a rat model of experimental bacterial meningitis. J. Cereb. Blood Flow Metab. 17:1221-1229.
33. Weber, J. R., D. Freyer, C. Alexander, N. W. J. Schröder, A. Reiss, C. Küster, D. Pfeil, E. I. Tuomanen, and R. R. Schumann. 2003. Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein. Immunity 19:269-279.
34. Weber, J. R., P. Moreillon, and E. I. Tuomanen. 2003. Innate sensors for gram-positive bacteria. Curr. Opin. Immunol. 15:408-415.
35. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1-5.